MyAverix Finance
F · Healthcare
MOLECULE HOLDINGS (ERV2)
Drug Manufacturers - Specialty & Generic
MOLECULE HOLDINGS (ERV2) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ERV2
MOLECULE HOLDINGS (ERV2) — FAQ
What is ERV2's P/E ratio?
The price-to-earnings (P/E) ratio for MOLECULE HOLDINGS (ERV2) is 18.00 (data as of 2026-05-23).
Does MOLECULE HOLDINGS pay a dividend?
Dividend yield is not available in the current snapshot for MOLECULE HOLDINGS (ERV2). Check the MyAverix Finance app for the latest dividend data.
What sector is MOLECULE HOLDINGS in?
MOLECULE HOLDINGS (ERV2) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ERV2 listed on?
ERV2 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.